OPKO Health, Inc. (OPK)

Market Cap	1.24B
Revenue (ttm)	868.08M
Net Income (ttm)	-209.23M
Shares Out	773.06M
EPS (ttm)	-0.28
PE Ratio	n/a
Forward PE	64.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,186,595
Open	1.57
Previous Close	1.50
Day's Range	1.52 - 1.60
52-Week Range	1.00 - 2.24
Beta	1.76
Analysts	Strong Buy
Price Target	2.50 (+56.25%)
Earnings Date	Nov 7, 2023

About OPK

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers,...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 2, 1995
• Employees: 4,196
• Stock Exchange: NASDAQ
• Ticker Symbol: OPK

Financial Performance

In 2022, OPKO Health's revenue was $1.00 billion, a decrease of -43.42% compared to the previous year's $1.77 billion. Losses were -$328.41 million, 989.5% more than in 2021.

Analyst Forecast

According to 2 analysts, the average rating for OPK stock is "Strong Buy." The 12-month stock price forecast is $2.5, which is an increase of 56.25% from the latest price.

Price Target

$2.5

(56.25% upside)

Analyst Consensus: Strong Buy